Farther Finance Advisors, LLC Tg Therapeutics, Inc. Put Options Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TGTX
# of Institutions
413Shares Held
87.8MCall Options Held
2.36MPut Options Held
1.96M-
Vanguard Group Inc Valley Forge, PA15.8MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$309 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$207 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$94.7 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$82.8 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.94B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...